Skip to content

Effects of Aquatic Aerobic Exercise on Cardiopulmonary Function and Quality of Life in Older Patients With Coronary Heart Disease: A Randomized Controlled Trial

Effects of Aquatic Aerobic Exercise on Cardiopulmonary Function and Quality of Life in Older Patients With Coronary Heart Disease: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125078
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-05-24
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Experimental Group:Aquatic Aerobic Exercise
Control Group:Conventional secondary prevention pharmacotherapy for coronary heart disease and health education

Sponsors

Geriatric Hospital of Hainan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosed with coronary heart disease (CHD) in a stable condition. 2.Aged 60–80 years. 3.New York Heart Association (NYHA) functional class II–III. 4.Normal cognitive function, capable of cooperating with training and assessments. 5.Voluntary participation with signed written informed consent.

Exclusion criteria

Exclusion criteria: 1.Acute myocardial infarction, unstable angina, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG) within the past 3 months. 2.Severe arrhythmia, uncontrolled hypertension (systolic blood pressure =180 mmHg and/or diastolic blood pressure >=110 mmHg), or congenital heart disease. 3.Severe hepatic or renal dysfunction (Child-Pugh Class C or estimated glomerular filtration rate [eGFR] <30 mL·min^-1·1.73 m^-2). 4.Contraindications to aquatic environment, such as uncontrolled skin infection or severe incontinence. 5.Concurrent neurological, muscular, or skeletal disorders affecting exercise assessment or training execution. 6.Participation in other clinical trials or systematic exercise interventions within the past 3 months. 7.Any other condition deemed by the investigator as unsuitable for study participation.

Design outcomes

Primary

MeasureTime frame
VO2max/kg;

Secondary

MeasureTime frame
Absolute peak oxygen uptake;Metabolic equivalents ;Anaerobic threshold;Peak power ;Left ventricular ejection fraction;Left ventricular end-diastolic diameter;Assessed by the Seattle Angina Questionnaire;Assessed by the SF-36 Health Survey;

Countries

China

Contacts

Public ContactWang Jianqiang

Geriatric Hospital of Hainan

wangjianqiang1984@126.com+86 188 0896 8095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026